Loading...
China Sanjiang Fine Chemicals Company Limited
CNSJF•PNK
Basic Materials
Chemicals
$0.16
$0.00(0.00%)
China Sanjiang Fine Chemicals Company Limited (CNSJF) Financial Performance & Income Statement Overview
Review China Sanjiang Fine Chemicals Company Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
49.19%
↑ 49.19%
Operating Income Growth
2465.90%
↑ 2465.90%
Net Income Growth
482.17%
↑ 482.17%
Operating Cash Flow Growth
100.00%
↑ 100.00%
Operating Margin
2.28%
↑ 2.28%
Gross Margin
3.58%
↑ 3.58%
Net Profit Margin
1.23%
↑ 1.23%
ROE
4.65%
↑ 4.65%
ROIC
4.81%
↑ 4.81%
China Sanjiang Fine Chemicals Company Limited (CNSJF) Income Statement & Financial Overview
Review China Sanjiang Fine Chemicals Company Limited's (CNSJF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $10.35B | $9.24B | $8.54B | $4.59B |
| Cost of Revenue | $9.61B | $8.90B | $8.24B | $4.72B |
| Gross Profit | $735.89M | $339.84M | $296.70M | -$127.94M |
| Gross Profit Ratio | $0.07 | $0.04 | $0.03 | -$0.03 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $124.61M | $111.79M | $120.004M | $84.24M |
| Operating Expenses | $124.61M | $111.79M | $120.004M | $122.31M |
| Total Costs & Expenses | $9.73B | $9.01B | $8.36B | $4.84B |
| Interest Income | $0.00 | $0.00 | $176.07M | $38.83M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $30.19M | $515.15M | $295.39M | $249.96M |
| EBITDA | $617.65M | $735.87M | $901.49M | -$395.29M |
| EBITDA Ratio | $0.06 | $0.08 | $0.11 | -$0.09 |
| Operating Income | $611.27M | $228.06M | $176.70M | -$645.25M |
| Operating Income Ratio | $0.06 | $0.02 | $0.02 | -$0.14 |
| Other Income/Expenses (Net) | -$228.55M | -$63.63M | -$112.03M | $167.72M |
| Income Before Tax | $382.72M | $164.43M | $64.66M | -$44.46M |
| Income Before Tax Ratio | $0.04 | $0.02 | $0.008 | -$0.010 |
| Income Tax Expense | $3.14M | $10.06M | $27.90M | $51.82M |
| Net Income | $378.50M | $154.06M | $65.36M | $26.12M |
| Net Income Ratio | $0.04 | $0.02 | $0.008 | $0.006 |
| EPS | $0.33 | $0.13 | $0.06 | $0.02 |
| Diluted EPS | $0.33 | $0.13 | $0.06 | $0.02 |
| Weighted Avg Shares Outstanding | $1.16B | $1.16B | $1.16B | $1.18B |
| Weighted Avg Shares Outstanding (Diluted) | $1.16B | $1.16B | $1.16B | $1.18B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan